Shares in infection prevention specialist Tristel (TSTL) surged this week, as strong first half trading and another bullish outlook reminded investors that at least one Aim-listed company is benefiting from the ascent of viral threats to the top of the global risk agenda.
IC TIP:
Buy
at
441p